Skip to main content
AFYAAfya LimitedBuy Wait5.9·$14.68-0.34%
Buy WaitModerate Confidence
Investment thesis

Afya trades at a notably low forward P/E of 6.9x with a near-perfect Piotroski score and three beats in the last four quarters, but soft revenue growth and a momentum profile that has yet to recover above the long-term average require patience at entry.

Thesis pillars

  • Momentum Below Entry ThresholdDeteriorating
  • High Quality Franchise MarginsStable
  • Deeply Discounted ValuationStable
  • +2 more pillars — see the Why tab for full reasoning

Full reasoning →

Open full analysis

Afya Limited (AFYA) Stock Analysis

Breakout setup · Inst Constrain edge

Buy WaitValueQualityModerate Confidence

Consumer Defensive · Education & Training Services

Wait for pullback to $13.45. At $14.68 the A.R:R is 0.1:1 — below the 1.5:1 minimum for BUY_NOW. Engine's entry $13.45 (support + ATR (held)) is the shallowest technical level that clears the 2:1 A.R:R minimum. Key risk: Analyst target reached - limited upside remaining.

Afya Limited operates as a medical education group in Brazil. The company operates in three segments: Undergraduate, Continuing Education, and Medical Practice Solutions. The Undergraduate segment offers educational services through undergraduate courses related to medical... Read more

$14.68+1.3% A.UpsideScore 5.9/10#11 of 18 Education & Training Services
QualityF-score9 / 9FCF yield29.76%
IncomeYield4.47%Payout39.93%sustainable
Entry $13.45(support + ATR (held))Stop $12.56Target $14.87(analyst − 13%)A.R:R 0.1:1
Analyst target$17.09+16.5%9 analysts
$14.87our TP
$14.68price
$17.09mean
$21

Wait for pullback to $13.45. At $14.68 the A.R:R is 0.1:1 — below the 1.5:1 minimum for BUY_NOW. Engine's entry $13.45 (support + ATR (held)) is the shallowest technical level that clears the 2:1 A.R:R minimum. Key risk: Analyst target reached - limited upside remaining. Chart setup: Golden cross, above all MAs, RSI 69, MACD bullish. Fundamentals strong but target reached (1.3% upside). Wait for pullback. Score 5.9/10, moderate confidence.

Passes 7/8 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, earnings proximity 68d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: aggressive.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Thu, Nov 12, 202668d to earnings· next earnings call

Thesis

Rewards
V7 quality resilience bonus: +0.2 (Q=7.6 in RISK_OFF)
Sector modifier (Consumer Defensive): +0.8
Strong earnings beat streak (3/4)
Risks
Analyst target reached - limited upside remaining

Key Metrics

P/E (TTM)8.7
P/E (Fwd)7.3
Mkt Cap$1.3B
EV/EBITDA2.3
Profit Mgn20.4%
ROE16.7%
Rev Growth5.7%
Beta0.38
Dividend4.47%
Rating analysts13

Quality Signals

Piotroski F9/9MoatNarrow

Options Flow

P/C0.13bullish
IV74%elevated
Max Pain$13-14.9% vs spot

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

10 dimensions · all in-band

GatesA.R:R 0.1 < 1.5@spotMomentum 6.1>=5.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 68d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARBreakoutSuitability: Aggressive
RSI
69 · Neutral
20D MA 50D MA 200D MAGOLDEN CROSSSupport $13.22Resistance $15.12

Price Targets

$13
$13
$15
A.Upside+1.3%
A.R:R0.1:1

Position Sizing

ConvictionHigh conviction
Suggested %1%
Max %2%
RegimeRisk-Off

Risk Alerts

! Target reached (1.3% upside)
! asymmetry at 0.1 (below the engine's 1.5 threshold)@spot

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-11-12 (68d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is AFYA stock a buy right now?

Wait for pullback to $13.45. At $14.68 the A.R:R is 0.1:1 — below the 1.5:1 minimum for BUY_NOW. Engine's entry $13.45 (support + ATR (held)) is the shallowest technical level that clears the 2:1 A.R:R minimum. Key risk: Analyst target reached - limited upside remaining. Chart setup: Golden cross, above all MAs, RSI 69, MACD bullish. Fundamentals strong but target reached (1.3% upside). Wait for pullback. Target $14.87 (+1.3%), stop $12.56 (−16.9%), A.R:R 0.1:1. Score 5.9/10, moderate confidence.

What is the AFYA stock price target?

Take-profit target: $14.87 (+1.3% upside). Target $14.87 (+1.3%), stop $12.56 (−16.9%), A.R:R 0.1:1. Stop-loss: $12.56.

What are the risks of investing in AFYA?

Analyst target reached - limited upside remaining.

Is AFYA overvalued or undervalued?

Afya Limited trades at a P/E of 8.7 (forward 7.3). TrendMatrix value score: 7.7/10. Verdict: Buy (Wait for Entry).

What do analysts say about AFYA?

13 analysts cover AFYA with a consensus score of 2.5/5. Average price target: $17.

What does Afya Limited do?Afya Limited operates as a medical education group in Brazil. The company operates in three segments: Undergraduate,...

Afya Limited operates as a medical education group in Brazil. The company operates in three segments: Undergraduate, Continuing Education, and Medical Practice Solutions. The Undergraduate segment offers educational services through undergraduate courses related to medical school, health sciences, and other non-health undergraduate programs, including medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, biomedicine, business administration, accounting, law, civil and industrial engineering, and pedagogy. The Continuing Education segment provides medical education, including residency preparation programs, specialization test preparation, graduate courses in medicine, and digital and in-person professional development for physicians and medical students. The Medical Practice Solutions segment offers clinical decision support platforms, medical practice management software, healthcare financial services, and digital healthcare ecosystem solutions, such as electronic medical records, practice management tools, telemedicine, digital prescriptions, and doctor-patient relationship platforms. This segment also provides a subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. The company also offers educational health and medical imaging; and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. In addition, it offers printed and digital content, as well as an online medical education platform and physicians, healthcare professionals and students. Afya Limited was founded in 1999 and is headquartered in Belo Horizonte, Brazil.

Related stocks: TAL (TAL Education Group) · PXED (Phoenix Education Partners, Inc) · COUR (Coursera, Inc.) · PRDO (Perdoceo Education Corporation) · LRN (Stride, Inc.)
Home Stocks AFYA

Latest news

Latest News

MarketBeat6d agoCONCERNAnalyst
Yahoo Finance38d ago
Thelegaladvocate.com101d ago
Thelegaladvocate.com102d ago
Thelegaladvocate.com102d ago
Soko Directory45d ago
Yahoo Finance108d ago
MarketBeat31d agoEarnings
The Globe and Mail94d ago
TipRanks67d ago
GuruFocus67d ago
Simplywall.st68d ago
Revelio Labs40d ago
TradingKey40d ago
Tradingkey.com40d ago
TradingKey40d ago
MarketBeat131d agoAnalyst
Thelegaladvocate.com102d ago
Thelegaladvocate.com103d ago
Valor International11d agoMerger Acquisition
Loading more...